Curaleaf sweetens Aurora Cannabis takeover offer
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Curaleaf Holdings Inc. says it will sweeten the offer it’s made to buy rival pot firm Aurora Cannabis Inc.
Stamford, Conn.-based Curaleaf now wants to make an offer valued at US$5 per Aurora share. The offer will be comprised of 0.4013 Curaleaf shares plus US$1 cash, based on Curaleaf’s Oct. 2 closing share price.
The company says it’s boosting its bid despite Aurora rebuffing its past overtures because Curaleaf wants to signal it’s trying to negotiate in good faith and show it’s worth combining the cannabis businesses.
Over the summer, Curaleaf made a bid for the Edmonton-based company that was worth US$4 per Aurora share.
That bid included 0.3463 of a Curaleaf subordinate voting share plus 75 cents US in cash, based on its closing share price on Aug. 10.
Aurora urged shareholders to reject Curaleaf’s initial hostile takeover bid, saying the offer undervalued Aurora and was not in the best interests of shareholders.
“Today’s announcement by Curaleaf is not a formal revised bid, and Aurora has not yet received the materials required to conduct a full and proper evaluation,” Miguel Martin, Aurora CEO, says in a news release.
“While the announcement suggests an intention to address concerns Aurora identified with Curaleaf’s initial Hostile Bid, the Special Committee of independent directors will review any formal revised offer once received with the same rigorous, independent and disciplined process applied previously.”
This report by The Canadian Press was first published Oct. 5, 2026.
Companies in this story: (TSX: ACB, TSX: CURA)
